Trials / Recruiting
RecruitingNCT07244939
Cephea South America Feasibility Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cephea Mitral Valve System | Cephea Mitral Valve System |
Timeline
- Start date
- 2025-06-17
- Primary completion
- 2026-09-01
- Completion
- 2028-09-01
- First posted
- 2025-11-24
- Last updated
- 2026-02-06
Locations
3 sites across 2 countries: Brazil, Chile
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07244939. Inclusion in this directory is not an endorsement.